Krishna, B.A., Spiess, K., Poole, E.L., Lau, B. , Voigt, S., Kledal, T.N., Rosenkilde, M.M. and Sinclair, J.H. (2017) Targeting the latent cytomegalovirus reservoir with an antiviral fusion toxin protein. Nature Communications, 8, 14321. (doi: 10.1038/ncomms14321) (PMID:28148951) (PMCID:PMC5296658)
|
Text
137463.pdf - Published Version Available under License Creative Commons Attribution. 759kB |
Abstract
Reactivation of human cytomegalovirus (HCMV) in transplant recipients can cause life-threatening disease. Consequently, for transplant recipients, killing latently infected cells could have far-reaching clinical benefits. In vivo, myeloid cells and their progenitors are an important site of HCMV latency, and one viral gene expressed by latently infected myeloid cells is US28. This viral gene encodes a cell surface G protein-coupled receptor (GPCR) that binds chemokines, triggering its endocytosis. We show that the expression of US28 on the surface of latently infected cells allows monocytes and their progenitor CD34+ cells to be targeted and killed by F49A-FTP, a highly specific fusion toxin protein that binds this viral GPCR. As expected, this specific targeting of latently infected cells by F49A-FTP also robustly reduces virus reactivation in vitro. Consequently, such specific fusion toxin proteins could form the basis of a therapeutic strategy for eliminating latently infected cells before haematopoietic stem cell transplantation.
Item Type: | Articles |
---|---|
Additional Information: | This work was funded by the British Medical Research programme Grant G0701279 (to J.H.S.), Wellcome Research Studentship Grant (to B.A.K.), the Hørslev Foundation (to M.M.R.) and the Cambridge NIHR BRC Cell Phenotyping Hub. |
Status: | Published |
Refereed: | Yes |
Glasgow Author(s) Enlighten ID: | Lau, Dr Betty |
Authors: | Krishna, B.A., Spiess, K., Poole, E.L., Lau, B., Voigt, S., Kledal, T.N., Rosenkilde, M.M., and Sinclair, J.H. |
College/School: | College of Medical Veterinary and Life Sciences > School of Infection & Immunity |
Journal Name: | Nature Communications |
Publisher: | Nature Research |
ISSN: | 2041-1723 |
ISSN (Online): | 2041-1723 |
Copyright Holders: | Copyright © 2017 The Authors |
First Published: | First published in Nature Communications 8: 14321 |
Publisher Policy: | Reproduced under a Creative Commons License |
University Staff: Request a correction | Enlighten Editors: Update this record